Dionics, Inc. (DION.OB) Announces Progress in Initiative Aimed at Expanding Asian Market
Yesterday, Dionics, Inc. announced the progress they have made in regards to generating growth in the expanding Chinese market. Dionics,…
Blog
InSite Vision Inc. (INSV.OB) Awarded Therapeutic Discovery Project Grant
InSite Vision Inc. announced yesterday that they will receive $489,000 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.…
Access Pharmaceuticals, Inc. (ACCP.OB) Commences Phase II Trial for Ovarian Drug
Access Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of…
eDoorways International Corp. (EDWY.PK) Engages Investor Relations Firm for Additional Support
Today before the opening bell, eDoorways International Corp. announced that they have retained ATG Capital to provide additional Investor Relations…
IDO Security, Inc. (IDOI.OB) Announces Participation at the Israel Homeland Security International Conference
IDO Security, Inc., developer of the innovative Magshoe™ shoe scanning device, announced earlier today that it exhibited its new MagShoe™…
PDC Energy (PDC) Purchases Oil and Gas Assets in Texas
PDC Energy reported that the company has entered into a purchase agreement to buy producing oil and gas properties in…
Gasco Energy, Inc. (GSX) Reports Increase in Revenue for the Third Quarter of 2010
Gasco Energy, Inc. reported an increase in revenues during the third quarter of 2010 as the company benefited both from…
CleanTech Innovations, Inc. (EVCP.OB) Customer Order Fulfillment Drives Impressive Q3 Results
CleanTech Innovations Inc. is a U.S. company with leading operations in China's clean technology, wind tower industry. The company today…
Blue Earth, Inc. (BBLU.OB) is “One to Watch”
Blue Earth, Inc. is focused on pursuing opportunities in the rapidly growing, multi-billion dollar, energy efficiency sector. The company has…
Neuralstem, Inc. (CUR) Receives Some $733K in Federal Grants to Develop Breakthrough Central Nervous System Therapies
Neuralstem, www.neuralstem.com – the biotherapeutics developer leveraging patented stem cell technology for commercial-quantity production of differentiable human brain/spinal cord cells…